These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 12654425

  • 1. A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma.
    Marcus KJ, Dutton SC, Barnes P, Coleman CN, Pomeroy SL, Goumnerova L, Billett AL, Kieran M, Tarbell NJ.
    Int J Radiat Oncol Biol Phys; 2003 Apr 01; 55(5):1182-5. PubMed ID: 12654425
    [Abstract] [Full Text] [Related]

  • 2. Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma.
    Haas-Kogan DA, Banerjee A, Kocak M, Prados MD, Geyer JR, Fouladi M, McKnight T, Poussaint TY, Broniscer A, Blaney SM, Boyett JM, Kun LE.
    Neuro Oncol; 2008 Jun 01; 10(3):341-7. PubMed ID: 18417739
    [Abstract] [Full Text] [Related]

  • 3. Survival results from a phase I study of etanidazole (SR2508) and radiotherapy in patients with malignant glioma.
    Chang EL, Loeffler JS, Riese NE, Wen PY, Alexander E, Black PM, Coleman CN.
    Int J Radiat Oncol Biol Phys; 1998 Jan 01; 40(1):65-70. PubMed ID: 9422559
    [Abstract] [Full Text] [Related]

  • 4. A phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas.
    Allen J, Siffert J, Donahue B, Nirenberg A, Jakacki R, Robertson P, DaRosso R, Thoron L, Rosovsky M, Pinto R.
    Cancer; 1999 Sep 15; 86(6):1064-9. PubMed ID: 10491535
    [Abstract] [Full Text] [Related]

  • 5. Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma.
    Broniscer A, Baker JN, Tagen M, Onar-Thomas A, Gilbertson RJ, Davidoff AM, Pai Panandiker AS, Leung W, Chin TK, Stewart CF, Kocak M, Rowland C, Merchant TE, Kaste SC, Gajjar A.
    J Clin Oncol; 2010 Nov 01; 28(31):4762-8. PubMed ID: 20921456
    [Abstract] [Full Text] [Related]

  • 6. A phase I study of topotecan as a radiosensitizer for brainstem glioma of childhood: first report of the Children's Cancer Group-0952.
    Sanghavi SN, Needle MN, Krailo MD, Geyer JR, Ater J, Mehta MP.
    Neuro Oncol; 2003 Jan 01; 5(1):8-13. PubMed ID: 12626128
    [Abstract] [Full Text] [Related]

  • 7. Radiation therapy and high-dose tamoxifen in the treatment of patients with diffuse brainstem gliomas: results of a Brazilian cooperative study. Brainstem Glioma Cooperative Group.
    Broniscer A, Leite CC, Lanchote VL, Machado TM, Cristófani LM.
    J Clin Oncol; 2000 Mar 01; 18(6):1246-53. PubMed ID: 10715294
    [Abstract] [Full Text] [Related]

  • 8. National Cancer Institute (phase II) study of high-grade glioma treated with accelerated hyperfractionated radiation and iododeoxyuridine: results in anaplastic astrocytoma.
    Sullivan FJ, Herscher LL, Cook JA, Smith J, Steinberg SM, Epstein AH, Oldfield EH, Goffman TE, Kinsella TJ, Mitchell JB.
    Int J Radiat Oncol Biol Phys; 1994 Oct 15; 30(3):583-90. PubMed ID: 7928489
    [Abstract] [Full Text] [Related]

  • 9. Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial.
    Souweidane MM, Kramer K, Pandit-Taskar N, Zhou Z, Haque S, Zanzonico P, Carrasquillo JA, Lyashchenko SK, Thakur SB, Donzelli M, Turner RS, Lewis JS, Cheung NV, Larson SM, Dunkel IJ.
    Lancet Oncol; 2018 Aug 15; 19(8):1040-1050. PubMed ID: 29914796
    [Abstract] [Full Text] [Related]

  • 10. A phase I study of etanidazole and radiotherapy in malignant glioma.
    Riese NE, Loeffler JS, Wen P, Alexander E, Black PM, Coleman CN.
    Int J Radiat Oncol Biol Phys; 1994 Jun 15; 29(3):617-20. PubMed ID: 8005825
    [Abstract] [Full Text] [Related]

  • 11. Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02.
    Werner-Wasik M, Scott CB, Nelson DF, Gaspar LE, Murray KJ, Fischbach JA, Nelson JS, Weinstein AS, Curran WJ.
    Cancer; 1996 Apr 15; 77(8):1535-43. PubMed ID: 8608540
    [Abstract] [Full Text] [Related]

  • 12. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy.
    Mandell LR, Kadota R, Freeman C, Douglass EC, Fontanesi J, Cohen ME, Kovnar E, Burger P, Sanford RA, Kepner J, Friedman H, Kun LE.
    Int J Radiat Oncol Biol Phys; 1999 Mar 15; 43(5):959-64. PubMed ID: 10192340
    [Abstract] [Full Text] [Related]

  • 13. Single-arm, open-label phase II study of intravenously administered tirapazamine and radiation therapy for glioblastoma multiforme.
    Del Rowe J, Scott C, Werner-Wasik M, Bahary JP, Curran WJ, Urtasun RC, Fisher B.
    J Clin Oncol; 2000 Mar 15; 18(6):1254-9. PubMed ID: 10715295
    [Abstract] [Full Text] [Related]

  • 14. Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report.
    Pollack IF, Jakacki RI, Blaney SM, Hancock ML, Kieran MW, Phillips P, Kun LE, Friedman H, Packer R, Banerjee A, Geyer JR, Goldman S, Poussaint TY, Krasin MJ, Wang Y, Hayes M, Murgo A, Weiner S, Boyett JM.
    Neuro Oncol; 2007 Apr 15; 9(2):145-60. PubMed ID: 17293590
    [Abstract] [Full Text] [Related]

  • 15. Phase I study of weekly topotecan combined to concurrent external cranial irradiation in adults with glioblastoma multiforme of the brain.
    Varveris H, Petinelli E, Stratakis J, Mazonakis M.
    Oncol Rep; 2008 Feb 15; 19(2):447-55. PubMed ID: 18202794
    [Abstract] [Full Text] [Related]

  • 16. A phase I trial of 96-hour paclitaxel infusion plus accelerated radiotherapy of unrespectable head and neck cancer.
    Machtay M, Aviles V, Kligerman MM, Treat J, Weinstein GS, Weber RS, Mirza N, Chalian AA, Rosenthal DI.
    Int J Radiat Oncol Biol Phys; 1999 May 01; 44(2):311-5. PubMed ID: 10760424
    [Abstract] [Full Text] [Related]

  • 17. A phase I study of cranial radiation therapy with concomitant continuous infusion paclitaxel in children with brain tumors.
    Liu L, Vapiwala N, Munoz LK, Winick NJ, Weitman S, Strauss LC, Frankel LS, Rosenthal DI.
    Med Pediatr Oncol; 2001 Oct 01; 37(4):390-2. PubMed ID: 11568904
    [Abstract] [Full Text] [Related]

  • 18. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
    Kuhnt T, Becker A, Pigorsch S, Pelz T, Bloching M, Passmann M, Lotterer E, Hänsgen G, Dunst J.
    Strahlenther Onkol; 2003 Oct 01; 179(10):673-81. PubMed ID: 14566475
    [Abstract] [Full Text] [Related]

  • 19. 3D conformal radiotherapy and cisplatin for recurrent malignant glioma.
    VanderSpek L, Fisher B, Bauman G, Macdonald D.
    Can J Neurol Sci; 2008 Mar 01; 35(1):57-64. PubMed ID: 18380278
    [Abstract] [Full Text] [Related]

  • 20. A detrimental effect of a combined chemotherapy-radiotherapy approach in children with diffuse intrinsic brain stem gliomas?
    Freeman CR, Kepner J, Kun LE, Sanford RA, Kadota R, Mandell L, Friedman H.
    Int J Radiat Oncol Biol Phys; 2000 Jun 01; 47(3):561-4. PubMed ID: 10837936
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.